Cargando…
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
We aimed to investigate vaccine effectiveness against progression to severe COVID-19 (acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission and/or death) and in-hospital death in a cohort of hospitalized COVID-19 patients. Mixed effects logistic regression analyses were per...
Autores principales: | Robalo, Queeny, De Mot, Laurane, Vandromme, Mathil, Van Goethem, Nina, Gabrio, Andrea, Chung, Pui Yan Jenny, Meurisse, Marjan, Catteau, Lucy, Thijs, Carel, Blot, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866568/ https://www.ncbi.nlm.nih.gov/pubmed/36679859 http://dx.doi.org/10.3390/vaccines11010014 |
Ejemplares similares
-
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
por: Van Goethem, Nina, et al.
Publicado: (2022) -
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients
por: Van Goethem, Nina, et al.
Publicado: (2021) -
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data
por: Meurisse, Marjan, et al.
Publicado: (2022) -
Sévérité de l'infection par le variant Delta du SARS-CoV-2 chez les patients hospitalisés en Belgique
por: Meurisse, M., et al.
Publicado: (2022) -
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
por: Meurisse, Marjan, et al.
Publicado: (2023)